Cerinnov Statements
AL
Data from Cerinnov`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
EUR - Euro
Last reporting period:
31 Dec, 2023
Next reporting period:
28 Jun, 2024
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Cerinnov Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
8.064
25.2 %
100
3.39
42
4.674
14.3 %
58
—
0
2.29
28.4
3.95
-1.3 %
49
0.724
704.4 %
9
-0.046
-0.6
-0.046
-0.6
0.201
387.1 %
2.5
0.007
0.09
0.195
343.8 %
2.4
0.043
4.496
6.44
-20.7 %
100
2.35
36.5
4.09
-11.3 %
63.5
—
0
2.59
40.2
4
-2.7 %
62.1
0.09
-82 %
1.4
-0.05
-0.8
-0.05
-0.8
-0.07
-114.9 %
-1.09
0.01
0.2
-0.08
-125.8 %
-1.2
-0.02
4.5
8.12
25.5 %
100
3.51
43.2
4.61
32.1 %
56.8
—
0
2.54
31.3
4.11
9.3 %
50.6
0.5
285.2 %
6.2
-0.05
-0.6
-0.02
-0.2
0.47
171.2 %
5.8
0.16
2
0.31
145.6 %
3.8
0.07
4.5
6.47
12.3 %
100
2.98
46.1
3.49
-7.4 %
53.9
—
0
2.5
38.6
3.76
-5.5 %
58.1
-0.27
-28.6 %
-4.2
-0.02
-0.3
-0.04
-0.6
-0.66
-73.7 %
-10.2
0.02
0.3
-0.68
-88.9 %
-10.5
-0.15
4.5
5.76
29.7 %
100
1.99
34.5
3.77
40.1 %
65.5
—
0
2.5
43.4
3.98
6.4 %
69.1
-0.21
79.8 %
-3.6
-0.06
-1.04
-0.04
-0.7
-0.38
65.8 %
-6.6
-0.02
-0.3
-0.36
69.2 %
-6.3
-0.08
4.5
4.44
28.7 %
100
1.74
39.2
2.69
18.5 %
60.6
—
0
2.51
56.5
3.74
-7.2 %
84.2
-1.04
40.9 %
-23.4
-0.05
-1.1
-0.03
-0.7
-1.11
50.2 %
-25
0.05
1.1
-1.17
45.3 %
-26.4
-0.26
4.5
3.45
-10.6 %
100
1.18
34.2
2.27
14.1 %
65.8
—
0
2.75
79.7
4.03
1.3 %
116.8
-1.76
11.6 %
-51.01
-0.07
-2.03
-0.03
-0.9
-2.23
-4.7 %
-64.6
-0.11
-3.2
-2.14
-2.9 %
-62.03
-0.49
4.35
3.86
-45.3 %
100
1.87
48.4
1.99
-56.4 %
51.6
—
0
2.83
73.3
3.98
-28.9 %
103.1
-1.99
-91.3 %
-51.6
-0.04
-1.04
-0.04
-1.04
-2.13
-73.2 %
-55.2
-0.03
-0.8
-2.08
-66.4 %
-53.9
-0.48
4.35
7.06
-1.3 %
100
2.49
35.3
4.56
0.7 %
64.6
—
0
3.8
53.8
5.6
1.8 %
79.3
-1.04
-7.2 %
-14.7
-0.06
-0.8
-0.02
-0.3
-1.23
-17.1 %
-17.4
0.02
0.3
-1.25
-21.4 %
-17.7
-0.25
5.08
7.15
-29.3 %
100
2.62
36.6
4.53
-20.9 %
63.4
—
0
4.16
58.2
5.5
-11.4 %
76.9
-0.97
-102.1 %
-13.6
-0.05
-0.7
-0.04
-0.6
-1.05
-52.2 %
-14.7
—
0
-1.03
-47.1 %
-14.4
-0.28
3.63
10.11
27.8 %
100
4.38
43.3
5.73
25.9 %
56.7
—
0
3.98
39.4
6.21
31.6 %
61.4
-0.48
-166.7 %
-4.7
-0.05
-0.5
-0.01
-0.1
-0.69
-115.6 %
-6.8
0.03
0.3
-0.7
-191.7 %
-6.9
-0.19
3.69
7.91
25.6 %
100
3.37
42.6
4.55
35 %
57.5
—
0
3.55
44.9
4.72
15.1 %
59.7
-0.18
75.3 %
-2.3
-0.04
-0.5
—
0
-0.32
58.4 %
-4.05
-0.08
-1.01
-0.24
61.3 %
-3.03
-0.07
3.56
6.3
-19.7 %
100
2.93
46.5
3.37
-10.1 %
53.5
—
0
3.06
48.6
4.1
-5.5 %
65.1
-0.73
-23.7 %
-11.6
-0.04
-0.6
0.01
0.2
-0.77
-13.2 %
-12.2
-0.12
-1.9
-0.62
4.6 %
-9.8
-0.18
3.54
7.85
-30.7 %
100
4.1
52.2
3.75
-20.7 %
47.8
—
0
2.92
37.2
4.34
32.7 %
55.3
-0.59
-140.4 %
-7.5
-0.03
-0.4
-0.09
-1.1
-0.68
-144.7 %
-8.7
-0.02
-0.3
-0.65
-154.6 %
-8.3
-0.18
3.58
11.32
53.2 %
100
6.59
58.2
4.73
58.7 %
41.8
—
0
2.3
20.3
3.27
16.4 %
28.9
1.46
812.5 %
12.9
-0.05
-0.4
0.05
0.4
1.52
347.1 %
13.4
0.28
2.5
1.19
357.7 %
10.5
0.32
3.71
7.39
—
100
4.42
59.8
2.98
—
40.3
—
0
2.07
28
2.81
—
38
0.16
—
2.2
-0.07
-0.9
-0.03
-0.4
0.34
—
4.6
0.07
0.9
0.26
—
3.5
0.08
3.26